Clinical Trial Update: Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ferric carboxymaltose with or without phosphate substitution for iron deficiency or iron deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Donat R. Spahn | Conditions: Anemia, Iron-deficiency | Phase 4 | Status: COMPLETED